Deep Convolutional Neural Network-Based Lymph Node Metastasis Prediction for Colon Cancer Using Histopathological
Min Seob Kwak1, Hun Hee Lee1, Jae Min Yang2
1Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, South Korea.
Frontiers in Oncology
|February 1, 2021
Summary
A new computer-based analysis developed a peri-tumoral stroma (PTS) score to accurately predict lymph node metastasis (LNM) in colon cancer, aiding treatment decisions.
Area of Science:
- Oncology
- Pathology
- Computational Biology
Background:
- Accurate prediction of lymph node metastasis (LNM) is crucial for colon cancer treatment and follow-up.
- Current human evaluation of pathological slides has limitations in predicting LNM.
- There is a need for improved histopathological features for LNM prediction in colon cancer.
Purpose of the Study:
- To develop and validate accurate histopathological features for predicting LNM in colon cancer.
- To assess the predictive value of the peri-tumoral stroma (PTS) score for LNM.
- To establish a reproducible parameter for guiding colon cancer treatment decisions.
Main Methods:
- A deep convolutional neural network model was developed to analyze colon cancer tissue.
- The model was applied to whole-slide pathological images from The Cancer Genome Atlas (TCGA).
- The peri-tumoral stroma (PTS) score was assessed for its predictive value in LNM.
Main Results:
- Analysis of 164 TCGA patients with stages I-III colon cancer.
- Significantly higher PTS scores were observed in LNM-positive patients compared to LNM-negative patients (P < 0.001).
- PTS scores were significantly increased in cases with lymphatic invasion and other types of invasion in LNM-positive patients (P < 0.001).
Conclusions:
- The established PTS score is a simplified, reproducible parameter for predicting LNM in colon cancer.
- Computer-based analysis of the PTS score can aid in guiding treatment decisions for colon cancer.
- Further validation through large-scale prospective clinical trials is warranted.
Keywords:
colorectal cancerdeep learning–artificial neural networkhistologymetastasisprognostic score

